A novel non-canonical Wnt signature for prostate cancer aggressiveness.
about
Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model.SFRP4 gene expression is increased in aggressive prostate cancer.The Role and Mechanism of Epithelial-to-Mesenchymal Transition in Prostate Cancer Progression.WNT5A induces castration-resistant prostate cancer via CCL2 and tumour-infiltrating macrophages.Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy.
P2860
A novel non-canonical Wnt signature for prostate cancer aggressiveness.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A novel non-canonical Wnt signature for prostate cancer aggressiveness.
@en
A novel non-canonical Wnt signature for prostate cancer aggressiveness.
@nl
type
label
A novel non-canonical Wnt signature for prostate cancer aggressiveness.
@en
A novel non-canonical Wnt signature for prostate cancer aggressiveness.
@nl
prefLabel
A novel non-canonical Wnt signature for prostate cancer aggressiveness.
@en
A novel non-canonical Wnt signature for prostate cancer aggressiveness.
@nl
P2093
P2860
P356
P1433
P1476
A novel non-canonical Wnt signature for prostate cancer aggressiveness.
@en
P2093
Ailin Falkmo Hansen
Alan J Wright
Anna M Bofin
Elin Richardsen
Elise Sandsmark
Finn Drabløs
Helena Bertilsson
Kirsten M Selnæs
Morten B Rye
Trond Viset
P2860
P304
P356
10.18632/ONCOTARGET.14161
P407
P577
2016-12-24T00:00:00Z